Loading...
NPI 1215014022 · Hattiesburg, MS · Ophthalmologic Surgery Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Hattiesburg Eye Clinic Cataract & Lasik Surgery Center, LLC is a ophthalmologic surgery clinic/center provider located in Hattiesburg, Mississippi. This profile covers 18 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Hattiesburg Eye Clinic Cataract & Lasik Surgery Center, LLC |
| Address | 103 Millsaps Dr |
| City | Hattiesburg |
| State | MS |
| ZIP | 39402 |
| Taxonomy | Ophthalmologic Surgery Clinic/Center |
| NPI Enumerated | November 1, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.5M |
| Medicaid | $816.5K |
This provider reports $2.5M in total Medicare revenue and $816.5K in total Medicaid revenue, indicating Medicare is the dominant payer by scale for this practice. The disparity in absolute dollars shows the operation is more dependent on Medicare reimbursement streams than on Medicaid.
The provider’s Medicare revenue is heavily driven by cataract and intraoperative medication codes: 66984, J1097, and 66991 together account for 79.7% of the practice’s total Medicare revenue. That mix—primary cataract extraction with lens insertion plus high-volume use of phenylephrine/ketorolac irrigation (J1097)—is consistent with a surgical cataract/LASIK specialty center that relies on high-throughput, procedure-based care.
Medicaid revenue is even more concentrated: the top three Medicaid-revenue codes account for 100.0% of Medicaid revenue, and 66984 alone represents $798.1K (97.6% of the provider’s Medicaid revenue). This indicates the provider’s Medicaid business is effectively monocentric around cataract surgery with minimal ancillary Medicaid-reimbursed services.
On national performance for Medicare codes, J1097 is a clear outlier in volume: the provider ranks #16 of 443 nationally (97th percentile; notably above typical national volume for this code), signaling unusually high use of the phenylephrine/ketorolac irrigation relative to peers. By contrast, 66984 ranks #1138 of 15965 (93th percentile; typical, unremarkable volume for this code), which suggests cataract procedure counts are elevated compared with many providers but still within the expected range for cataract centers.
In-state competitive standing for Medicaid shows the provider is a significant cataract provider locally: 66984 ranks #6 of 42 in-state (88th percentile; typical, unremarkable volume for this code). J1097 also appears in the Medicaid top codes and ranks #4 of 11 in-state (70th percentile; typical, unremarkable volume), reinforcing that cataract procedures and associated intraoperative medication use form the core of the provider’s Medicaid footprint.
The code mix includes glaucoma- and retina-related procedures in Medicare billing (for example, 65820 with $111.6K representing 4.4% of Medicare revenue and 66821 with $140.8K representing 5.6%), plus device and vitreoretinal codes such as 66183 ($47.5K, 1.9%) and 67042 ($36.6K, 1.4%). These smaller but present service lines indicate the center performs a range of anterior- and posterior-segment procedures beyond routine cataract extraction, consistent with an ophthalmologic surgery clinic that handles complex surgical cases alongside high-volume cataract work.
The practice’s revenue concentration creates operational sensitivity: with the Medicare top three codes accounting for 79.7% of Medicare revenue and the Medicaid top three accounting for 100.0% of Medicaid revenue, shifts in cataract volume, reimbursement, or intraoperative medication utilization could meaningfully affect total revenue. Analysts should interpret performance and risk assuming a business model tied tightly to cataract procedural volume and perioperative medication use.
The NPI was enumerated on 2006-11-01 (~20 years ago), indicating an established presence in the market. That tenure, combined with the concentrated cataract surgery footprint and high relative utilization of J1097 on Medicare, suggests an entrenched surgical practice with sustained referral flows for cataract care.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,850 | $710 | $1.3M |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 7,140 | $80 | $542.6K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 70 | $2,160 | $153.3K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 810 | $170 | $140.8K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 120 | $920 | $111.6K |
| 66183 | The provider inserts a small device into the anterior chamber of the eye that helps to reduce the intraocular pressure of the eye in patients with glaucoma. | 30 | $1,900 | $47.5K |
| 67042 | In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina… | 30 | $1,310 | $36.6K |
| 66710 | The provider destroys a portion of ciliary body using a laser beam. This procedure decreases the fluid production in the eye, thereby decreasing intraocular pressure. | 50 | $560 | $30.3K |
| 67113 | The provider repairs a complicated detached retina. He removes vitreous humor, the gelatinous material that gives shape to the eye, and peels the retinal membrane. He reattaches the retina with… | 20 | $1,310 | $27.4K |
| 66180 | The provider implants a shunt in the anterior chamber of the eye to facilitate drainage of aqueous humor, or fluid, in order to reduce intraocular pressure. He uses a graft to reinforce the tissue… | 20 | $1,710 | $25.6K |
Showing 1–10 of 18
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
18 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1097 | 2 | 10 | 3,040 | $80 | $244.1K |
| J1096 | 8 | 10 | 840 | $100 | $150.6K |
| 66984 | 1 | 240 | 70 | $470 | $90.5K |
| 66991 | 3 | 20 | 40 | $1,300 | $62.6K |
| 67904 | 14 | 20 | 80 | $520 | $39K |
| 66183 | 3 | 10 | 20 | $1,430 | $37.1K |
| 65820 | 1 | 20 | 30 | $790 | $35.3K |
| 67042 | 6 | 10 | 30 | $1,000 | $27.9K |
| 66180 | 5 | 10 | 20 | $1,320 | $26.3K |
| 67036 | 12 | 10 | 20 | $890 | $25.7K |
Showing 1–10 of 18
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 3,020 | $260 | $798.1K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 380 | $40 | $14.5K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 70 | $70 | $5.2K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 80 | $1 | $80 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 650 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Mississippi providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Mississippi median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 6 | 40 | 300 | $180 | $191.9K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 8 | 10 | 160 | $50 | $18.3K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 4 | 10 | 190 | $20 | $12.9K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 5 | 10 | 130 | $10 | $1.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 25 | 60 | 520 | $1 | $200 |
Other providers in the same ZIP code as Hattiesburg Eye Clinic Cataract & Lasik Surgery Center, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.